Todd C. Davis, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 7,500 shares at $79.63 ($597K) on 2014-03-19, disclosed to the SEC on 2014-03-20.
Open-market sale of $597k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.45 | 2,500 | $199K | 33.3% |
| 2 | $79.63 | 5,000 | $398K | 66.7% |
| Total | $79.57 avg | 7,500 | $597K | 100% |
| Filing → |
| LGND | BUY | 2024-08-09 | $243K | — | Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |